Meredith Wright

University of California, Santa Cruz

Papers

3

Total Citations

26

H-Index

2

About

Meredith Wright is a bioprocess engineer whose research focuses on the rapid and stable production of HIV vaccine candidates using Chinese Hamster Ovary (CHO) cell lines. Her work addresses a critical bottleneck in HIV vaccine development: the notoriously low yields of envelope glycoproteins (Envs), which are often 10-100 times lower than other pharmaceutical proteins. Wright’s major contribution lies in pioneering robotic selection methods to accelerate the development of stable, high-producing CHO cell lines, dramatically shortening timelines for vaccine manufacturing. Her most cited paper (21 citations) demonstrates this approach for HIV Env production, while a subsequent study details the creation of a MGAT1⁻ CHO cell line that produces clade C gp120 with enhanced binding to broadly neutralizing antibodies—a key step toward a globally effective vaccine. Though early in her career, Wright’s work is strategically positioned at the intersection of automation and immunogen design, offering scalable solutions to one of the most challenging problems in bioprocessing. Her research is particularly relevant for students interested in cell line engineering, glycoprotein expression, and the practical hurdles of bringing HIV vaccines to the clinic.

Research Focus

Key Achievements

2
H-Index
3
Papers
26
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
Robotic selection for the rapid development of stable CHO cell lines for HIV vaccine production
21 citations · 2018
📈 Most Prolific Year: 2018 (3 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: University of California, Santa Cruz

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 5 days ago